Global Lung Cancer Liquid Biopsy Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243785

Publication Date:

November 29, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Lung Cancer Liquid Biopsy market size was valued at US$ 416.4 million in 2023. With growing demand in downstream market, the Lung Cancer Liquid Biopsy is forecast to a readjusted size of US$ 1076 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Lung Cancer Liquid Biopsy market. Lung Cancer Liquid Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lung Cancer Liquid Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lung Cancer Liquid Biopsy market.
Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer.
CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time.
Key Features:
The report on Lung Cancer Liquid Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lung Cancer Liquid Biopsy market. It may include historical data, market segmentation by Type (e.g., CTCs, CtDNA), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lung Cancer Liquid Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lung Cancer Liquid Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lung Cancer Liquid Biopsy industry. This include advancements in Lung Cancer Liquid Biopsy technology, Lung Cancer Liquid Biopsy new entrants, Lung Cancer Liquid Biopsy new investment, and other innovations that are shaping the future of Lung Cancer Liquid Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lung Cancer Liquid Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Lung Cancer Liquid Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lung Cancer Liquid Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lung Cancer Liquid Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lung Cancer Liquid Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lung Cancer Liquid Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lung Cancer Liquid Biopsy market.
Market Segmentation:
Lung Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
CTCs
CtDNA
Exosomes And RNA
Others
Segmentation by application
Clinics
Hospitals
Physicians' Office Laboratories
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biocept
Exosome Diagnostics
F. Hoffmann-La Roche
Qiagen
Accuragen
Agena Bioscience
Bard1
Bgi

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lung Cancer Liquid Biopsy Market Size 2019-2030
2.1.2 Lung Cancer Liquid Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lung Cancer Liquid Biopsy Segment by Type
2.2.1 CTCs
2.2.2 CtDNA
2.2.3 Exosomes And RNA
2.2.4 Others
2.3 Lung Cancer Liquid Biopsy Market Size by Type
2.3.1 Lung Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lung Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
2.4 Lung Cancer Liquid Biopsy Segment by Application
2.4.1 Clinics
2.4.2 Hospitals
2.4.3 Physicians' Office Laboratories
2.5 Lung Cancer Liquid Biopsy Market Size by Application
2.5.1 Lung Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lung Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
3 Lung Cancer Liquid Biopsy Market Size by Player
3.1 Lung Cancer Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Lung Cancer Liquid Biopsy Revenue by Players (2019-2024)
3.1.2 Global Lung Cancer Liquid Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Lung Cancer Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Lung Cancer Liquid Biopsy by Regions
4.1 Lung Cancer Liquid Biopsy Market Size by Regions (2019-2024)
4.2 Americas Lung Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.3 APAC Lung Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.4 Europe Lung Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Lung Cancer Liquid Biopsy Market Size Growth (2019-2024)
5 Americas
5.1 Americas Lung Cancer Liquid Biopsy Market Size by Country (2019-2024)
5.2 Americas Lung Cancer Liquid Biopsy Market Size by Type (2019-2024)
5.3 Americas Lung Cancer Liquid Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Liquid Biopsy Market Size by Region (2019-2024)
6.2 APAC Lung Cancer Liquid Biopsy Market Size by Type (2019-2024)
6.3 APAC Lung Cancer Liquid Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Lung Cancer Liquid Biopsy by Country (2019-2024)
7.2 Europe Lung Cancer Liquid Biopsy Market Size by Type (2019-2024)
7.3 Europe Lung Cancer Liquid Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lung Cancer Liquid Biopsy by Region (2019-2024)
8.2 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Lung Cancer Liquid Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Lung Cancer Liquid Biopsy Market Forecast
10.1 Global Lung Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Lung Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Lung Cancer Liquid Biopsy Forecast
10.1.3 APAC Lung Cancer Liquid Biopsy Forecast
10.1.4 Europe Lung Cancer Liquid Biopsy Forecast
10.1.5 Middle East & Africa Lung Cancer Liquid Biopsy Forecast
10.2 Americas Lung Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.2.1 United States Lung Cancer Liquid Biopsy Market Forecast
10.2.2 Canada Lung Cancer Liquid Biopsy Market Forecast
10.2.3 Mexico Lung Cancer Liquid Biopsy Market Forecast
10.2.4 Brazil Lung Cancer Liquid Biopsy Market Forecast
10.3 APAC Lung Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.3.1 China Lung Cancer Liquid Biopsy Market Forecast
10.3.2 Japan Lung Cancer Liquid Biopsy Market Forecast
10.3.3 Korea Lung Cancer Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Lung Cancer Liquid Biopsy Market Forecast
10.3.5 India Lung Cancer Liquid Biopsy Market Forecast
10.3.6 Australia Lung Cancer Liquid Biopsy Market Forecast
10.4 Europe Lung Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Lung Cancer Liquid Biopsy Market Forecast
10.4.2 France Lung Cancer Liquid Biopsy Market Forecast
10.4.3 UK Lung Cancer Liquid Biopsy Market Forecast
10.4.4 Italy Lung Cancer Liquid Biopsy Market Forecast
10.4.5 Russia Lung Cancer Liquid Biopsy Market Forecast
10.5 Middle East & Africa Lung Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Lung Cancer Liquid Biopsy Market Forecast
10.5.2 South Africa Lung Cancer Liquid Biopsy Market Forecast
10.5.3 Israel Lung Cancer Liquid Biopsy Market Forecast
10.5.4 Turkey Lung Cancer Liquid Biopsy Market Forecast
10.5.5 GCC Countries Lung Cancer Liquid Biopsy Market Forecast
10.6 Global Lung Cancer Liquid Biopsy Forecast by Type (2025-2030)
10.7 Global Lung Cancer Liquid Biopsy Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Biocept
11.1.1 Biocept Company Information
11.1.2 Biocept Lung Cancer Liquid Biopsy Product Offered
11.1.3 Biocept Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biocept Main Business Overview
11.1.5 Biocept Latest Developments
11.2 Exosome Diagnostics
11.2.1 Exosome Diagnostics Company Information
11.2.2 Exosome Diagnostics Lung Cancer Liquid Biopsy Product Offered
11.2.3 Exosome Diagnostics Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Exosome Diagnostics Main Business Overview
11.2.5 Exosome Diagnostics Latest Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Information
11.3.2 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Product Offered
11.3.3 F. Hoffmann-La Roche Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann-La Roche Main Business Overview
11.3.5 F. Hoffmann-La Roche Latest Developments
11.4 Qiagen
11.4.1 Qiagen Company Information
11.4.2 Qiagen Lung Cancer Liquid Biopsy Product Offered
11.4.3 Qiagen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qiagen Main Business Overview
11.4.5 Qiagen Latest Developments
11.5 Accuragen
11.5.1 Accuragen Company Information
11.5.2 Accuragen Lung Cancer Liquid Biopsy Product Offered
11.5.3 Accuragen Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Accuragen Main Business Overview
11.5.5 Accuragen Latest Developments
11.6 Agena Bioscience
11.6.1 Agena Bioscience Company Information
11.6.2 Agena Bioscience Lung Cancer Liquid Biopsy Product Offered
11.6.3 Agena Bioscience Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Agena Bioscience Main Business Overview
11.6.5 Agena Bioscience Latest Developments
11.7 Bard1
11.7.1 Bard1 Company Information
11.7.2 Bard1 Lung Cancer Liquid Biopsy Product Offered
11.7.3 Bard1 Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bard1 Main Business Overview
11.7.5 Bard1 Latest Developments
11.8 Bgi
11.8.1 Bgi Company Information
11.8.2 Bgi Lung Cancer Liquid Biopsy Product Offered
11.8.3 Bgi Lung Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Bgi Main Business Overview
11.8.5 Bgi Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂